Komori
Earnings presentation materials3002GUNZE LIMITEDMaterials and Chemicals

Financial Results Briefing Materials for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 (131st Fiscal Year)

During the interim period, net sales decreased 1.8% year on year, while operating profit increased 81.3%. Net income attributable to owners of the parent was ¥4,317 million, returning to profitability. The full-year consolidated earnings forecast was left unchanged, but forecasts were revised upward for Functional Solutions and Apparel and downward for Medical.

Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
2592
¥ millions (year-on-year change in operating income)
Wording
Conditional
How definitive the wording is.

Contents of this document

Earnings presentation materialsSecond quarter (interim period) of the fiscal year ending March 20279 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥64,082 million-1.8%
Operating profit¥5,778 million+81.3%
Ordinary income¥5,843 million+82.3%
Net income¥4,317 million
Operating profit margin9.0%, 4.9% in the prior-year period, +4.1 percentage points year on year
Results for the three months of the current quarter
Net Sales
¥32,714 million-1.0%
Operating profit
¥2,391 million+73.1%
Ordinary income
¥2,424 million+77.5%
Profit attributable to owners of parent for the quarter
¥1,676 million+105.9%
Full-year earnings forecast
Net Sales
¥132,000 million
Operating profit
¥8,800 million
Ordinary income
¥8,400 million
Profit attributable to owners of the parent
¥5,200 million
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Performance for the current interim consolidated accounting period was broadly within expectations
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Upward revision to the operating profit forecast for Functional Solutions+¥600 million
  • Downward revision to the operating profit forecast for Medical-¥800 million
  • Upward revision to the operating profit forecast for Apparel+¥200 million
  • Apparel business structural improvement costs (prior-year extraordinary income/loss)-¥3,498 million
New initiatives
  • Share repurchase (up to 1 million shares and ¥4 billion)
  • Promoting the establishment of a resource-circulation model centered on a Circular Factory
  • Reduction of Apparel brands and SKUs, site consolidation, and rationalization of indirect functions
  • Increasing engineering plastics production and constructing a new plant
Segment results
Functional Solutions
Net Sales
¥26,108 million+10.3%
Operating profit
¥5,249 million+56.9%
Medical
Net Sales
¥6,140 million-5.3%
Operating profit
¥709 million-25.2%
Apparel
Net Sales
¥26,745 million-10.2%
Operating profit
¥1,143 million+358.6%
Life Create
Net Sales
¥5,902 million+1.1%
Operating profit
¥606 million+27.7%
Financial targets
Equity ratio
71.3 %
Capital expenditures
¥3,813 million first half
Annual Dividend
Annual dividend per share
¥147
Payout ratio
130.2 %
DOE4.0% or more
Acquisition of treasury shares
Number of shares acquired
1,000,000 Shares maximum
Acquisition price
¥4,000 millions upper limit
PeriodFrom 6 November 2026 to 24 March 2027
Contents of this document
ItemDetails
Document typeEarnings presentation materials
Fiscal Period CoveredSecond quarter (interim period) of the fiscal year ending March 2027
Net Sales¥64,082 million (YoY -1.8%)
Operating profit¥5,778 million (YoY +81.3%)
Ordinary income¥5,843 million (YoY +82.3%)
Net income¥4,317 million
Operating profit margin9.0%, 4.9% in the prior-year period, +4.1 percentage points year on year
Results for the three months of the current quarterNet Sales ¥32,714 million (YoY -1.0%) / Operating profit ¥2,391 million (YoY +73.1%) / Ordinary income ¥2,424 million (YoY +77.5%) / Profit attributable to owners of parent for the quarter ¥1,676 million (YoY +105.9%)
Full-year earnings forecastNet Sales ¥132,000 million / Operating profit ¥8,800 million / Ordinary income ¥8,400 million / Profit attributable to owners of the parent ¥5,200 million
Self-assessment against the planPerformance for the current interim consolidated accounting period was broadly within expectations
Segment resultsFunctional Solutions Net Sales ¥26,108 million (YoY +10.3%) / Operating profit ¥5,249 million (YoY +56.9%) / Medical Net Sales ¥6,140 million (YoY -5.3%) / Operating profit ¥709 million (YoY -25.2%) / Apparel Net Sales ¥26,745 million (YoY -10.2%) / Operating profit ¥1,143 million (YoY +358.6%) / Life Create Net Sales ¥5,902 million (YoY +1.1%) / Operating profit ¥606 million (YoY +27.7%)
Breakdown of Factors Affecting the ChangeFactors Upward revision to the operating profit forecast for Functional Solutions / Amount +¥600 million, Factors Downward revision to the operating profit forecast for Medical / Amount -¥800 million, Factors Upward revision to the operating profit forecast for Apparel / Amount +¥200 million, Factors Apparel business structural improvement costs (prior-year extraordinary income/loss) / Amount -¥3,498 million
Financial targetsEquity ratio 71.3 %
Annual DividendAnnual dividend per share ¥147 / Interim and Year-End Breakdown Not disclosed
Payout ratio130.2 %
Acquisition of treasury sharesNumber of shares acquired 1,000,000 Shares (maximum) / Acquisition price ¥4,000 millions (upper limit) / Period From 6 November 2026 to 24 March 2027
Capital expenditures¥3,813 million (first half)
New initiativesShare repurchase (up to 1 million shares and ¥4 billion), Promoting the establishment of a resource-circulation model centered on a Circular Factory, Reduction of Apparel brands and SKUs, site consolidation, and rationalization of indirect functions, Increasing engineering plastics production and constructing a new plant
Items this document does not state (13)
Gross Profit MarginSelling, general and administrative expensesProgress against full-year forecastKey KPIsUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In plastic films, the time lag between changes in selling prices and raw material prices boosted profit. Improvements in the profitability of the overseas business, product cost improvements in Japan and overseas, and progress in the structural reform of the Apparel business also lifted operating profit. Net sales declined due to lower Apparel sales.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Briefing Materials for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 (131st Fiscal Year) | GUNZE LIMITED (3002) timely disclosure | Komori